Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (10): 1049-1052.DOI: 10.3969/j.issn.1673-8640.2020.10.020
Previous Articles Next Articles
Received:2019-09-16
Online:2020-10-30
Published:2020-11-12
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.10.020
| 分子特征 | 性别 | 例数 | 血液学参数 | ||||
|---|---|---|---|---|---|---|---|
| Hb/（g/L） | MCV/fL | MCH/pg | HbA2/% | Hb NewYork/% | |||
| 单纯Hb NewYork杂合子 | 男 | 21 | 151.0±8.3 | 86.3±4.2 | 28.8±1.6 | 3.0±0.5 | 44.5±1.1 |
| 女 | 36 | 119.0±14.2 | 86.0±7.2 | 28.5±3.2 | 3.0±0.2 | 43.8±2.2 | |
| Hb NewYork复合-α3.7杂合缺失 | 男 | 1 | 153 | 81.0 | 25.8 | 3.2 | 39.9 |
| Hb NewYork复合IVS-Ⅱ-81杂合突变 | 女 | 1 | 118 | 90.0 | 30.2 | 2.9 | 41.9 |
| 分子特征 | 性别 | 例数 | 血液学参数 | ||||
|---|---|---|---|---|---|---|---|
| Hb/（g/L） | MCV/fL | MCH/pg | HbA2/% | Hb NewYork/% | |||
| 单纯Hb NewYork杂合子 | 男 | 21 | 151.0±8.3 | 86.3±4.2 | 28.8±1.6 | 3.0±0.5 | 44.5±1.1 |
| 女 | 36 | 119.0±14.2 | 86.0±7.2 | 28.5±3.2 | 3.0±0.2 | 43.8±2.2 | |
| Hb NewYork复合-α3.7杂合缺失 | 男 | 1 | 153 | 81.0 | 25.8 | 3.2 | 39.9 |
| Hb NewYork复合IVS-Ⅱ-81杂合突变 | 女 | 1 | 118 | 90.0 | 30.2 | 2.9 | 41.9 |
| 新生儿Hb NewYork杂合子编号 | 性别 | 血液学参数 | ||
|---|---|---|---|---|
| HbA/% | HbF/% | Hb NewYork/% | ||
| 1 | 男 | 6.8 | 89.1 | 4.1 |
| 2 | 男 | 9.4 | 86.4 | 4.2 |
| 3 | 男 | 9.6 | 85.1 | 5.2 |
| 4 | 男 | 7.5 | 87.2 | 5.3 |
| 5 | 男 | 6.3 | 89.2 | 4.5 |
| 合计 | 7.9±1.5 | 87.4±1.8 | 4.7±0.6 | |
| 新生儿Hb NewYork杂合子编号 | 性别 | 血液学参数 | ||
|---|---|---|---|---|
| HbA/% | HbF/% | Hb NewYork/% | ||
| 1 | 男 | 6.8 | 89.1 | 4.1 |
| 2 | 男 | 9.4 | 86.4 | 4.2 |
| 3 | 男 | 9.6 | 85.1 | 5.2 |
| 4 | 男 | 7.5 | 87.2 | 5.3 |
| 5 | 男 | 6.3 | 89.2 | 4.5 |
| 合计 | 7.9±1.5 | 87.4±1.8 | 4.7±0.6 | |
| [1] | 徐湘民,张新华,陈荔丽. 地中海贫血预防控制操作指南[M]. 北京:人民军医出版社,2011. |
| [2] | 秦良谊. 我国β链异常血红蛋白发生率、基因频率和分布[J]. 医学研究通讯,2004,33(1):17-18. |
| [3] | 李友琼,黄慧嫔,阳文辉,等. 广西地区血红蛋白New York的血液学和分子特征[J]. 中华血液学杂志,2013,34(8):696-699. |
| [4] | 莫宗平,张玲,喻长顺,等. 异常血红蛋白81例基因分析[J]. 广东医学,2012,33(3):338-341. |
| [5] | 冉健,任振敏,裴元元,等. 深圳地区9 569例妊娠期妇女血红蛋白电泳结果分析[J]. 检验医学与临床,2014,11(20):2801-2802. |
| [6] | 温应方,林敏,刘桂荣,等. 广东梅州地区的异常血红蛋白的分子流行病学调查[J]. 重庆医科大学学报,2011,36(12):1496-1499. |
| [7] | 马占忠,杨辉,林敏,等. 广东韶关地区异常血红蛋白的分子流行病学调查[J]. 实用检验医师杂志,2014,6(3):179-181. |
| [8] | 李育敏,张水兰,阚丽娟,等. 罕见地中海贫血基因变异的分子特征与表型[J]. 检验医学,2019,34(7):613-616. |
| [9] | 张强,范歆,何升,等. Hb New York病ARMS-PCR检测及临床表型分析[J]. 临床检验杂志,2014,32(9):706-707. |
| [10] | 卢建,王继成,姚翠泽,等. 异常血红蛋白Hb New York的分子诊断及血液学特征分析[J]. 新医学,2018,49(6):421-424. |
| [11] | 陈冬,李萍,葛艳芬,等. 异常HbK复合β地中海贫血家系及其风险胎儿的产前诊断[J]. 南方医科大学学报,2009,29(11):2343-2344. |
| [12] | 吴教仁,林炳忠,陈钊. 血红蛋白E及血红蛋白E复合β地中海贫血的临床分析[J]. 临床血液学杂志,2004,17(4):204-206. |
| [13] | 赵颖,商璇,熊符,等. 异常血红蛋白(Hb J-Bangkok)合并β地中海贫血的临床表型分析[J]. 中华医学遗传学杂志,2013,30(2):148-151. |
| [14] | 郭浩,杜丽,唐斌,等. 脐血血红蛋白电泳在新生儿地中海贫血筛查中的应用[J]. 实用医学杂志,2014,30(12):1953-1955. |
| [15] | 唐健,何建萍,罗胜军,等. 6例异常血红蛋白K(Hb K)的基因型分析[J]. 昆明医科大学学报, 2018,39(9):91-94. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
